Photobiomodulation for Pediatric Hypertrophic Tonsils

Last updated: February 28, 2025
Sponsor: University of Alberta
Overall Status: Active - Recruiting

Phase

N/A

Condition

Sleep Disorders (Pediatric)

Sleep Apnea Syndromes

Treatment

PBM Tonsil Arm

Sham PBM Tonsil Arm

Clinical Study ID

NCT05459935
00103330
  • Ages 6-12
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Pediatric obstructive sleep apnea is a medical condition where a child has great difficulty with breathing, or stops breathing all together, while asleep. This is a medical condition for which the primary treatment is usually a surgery targeted towards removing swollen tonsils and adenoids. However, surgical removal of tonsils and adenoids comes with its own risks of complications during and after surgery including secondary hemorrhage and long term increased risks for respiratory and infectious diseases. Perhaps more importantly, surgical removal of swollen tonsils and adenoids does not guarantee successful treatment of a child's obstructive sleep apnea.

The use of laser light therapy in a non-cutting manner (known as photobiomodulation and abbreviated as PBM) has been a relatively new development within medicine. Recently, dentists have begun to use PBM as a method to treat adult snoring and, with lesser success, adult obstructive sleep apnea. To date, there are no known side effects to the use of PBM for the treatment of any sleep breathing disorders. However, no research has been published on the use of PBM for the treatment of pediatric obstructive sleep apnea or swollen tonsils in children

The purpose of this project is to determine whether photobiomodulation can provide a beneficial effect on pediatric hypertrophic tonsils and pediatric obstructive sleep apnea and, if it does, to create the appropriate workflow, referral pathways, and treatment parameters for clinicians to provide this treatment as a multidisciplinary approach in a clinical setting.

The investigators hypothesize that photobiomodulation can be used successfully to decrease the pediatric hypertrophic tonsils in children with symptoms of an pediatric obstructive sleep apnea and will also result in improved AHI scores (be able to breath significantly better when sleeping) in these children.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Brodsky visually graded tonsils 3/4

  • patient must assent, parent must consent, to all pre and post follow up includingsleep testing

  • patient and parent must agree to normal referral protocols regardless ofparticipation within this study or not

Exclusion

Exclusion Criteria:

  • visual indication of cancerous growth

  • currently under treatment (pharmacologic, other) for hypertrophic tonsils

  • already scheduled for surgical intervention of hypertrophic tonsils

Study Design

Total Participants: 64
Treatment Group(s): 2
Primary Treatment: PBM Tonsil Arm
Phase:
Study Start date:
October 15, 2022
Estimated Completion Date:
January 06, 2030

Connect with a study center

  • Enjoy Dental

    Edmonton, Alberta T5X 3N5
    Canada

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.